The Cancer Prognostics and Health Outcomes Unit of the University of Montreal, directed by Dr. Pierre Karakiewicz, in collaboration with several centers of excellence from around the world has developed a series of computerized devices to help patients and their physicians decide among the major treatment choices for several cancers and non-malignant conditions. The available applications, developed by Pierre Karakiewicz et al., can be used in prostate, bladder, kidney, adrenal and penile cancers, as well as in renal transplantation. Click here to access nomograms.

Kidney Cancer

Here is a list of available Kidney Cancer nomograms:

Before Nephrectomy

• Available nomograms for prediction of RCC before nephrectomy (NT)
• Nodal metastases - To predict the probability of lymph nodes at RCC diagnosis distant metastases - To predict the probability of distant metastases at RCC diagnosis
• High grade (Fuhrman III-IV) RCC - To predict the probability of high Fuhrman grade (3-4) at RCC diagnosis

After Nephrectomy - Available nomograms for prediction of RCC after nephrectomy (NT)

• Cause-specific mortality - Cause-specific mortality after nephrectomy for RCC.
• pT1-3, N0, M0 - Cause-specific mortality in patients with pT1-3, N0, M0.
• pT1-3, N1-2, M0 - Cause-specific mortality in patients with pN1-2, M0.
• pT1-3, N1-2, M1 - Cause-specific mortality in patients with M1.
• 30-day mortality after nephrectomy. - Cause-specific 30-day mortality after partial or radical nephrectomy.
• GFR loss partial nephrectomy -Glomerular Filtration Rate (GFR) decrease of 25% or more after partial nephrectomy.

Click here to access nomograms.